BIOPOR BioPorto A/S

0.1382USD0.9400 DKK · CPH-1.05%Mkt Cap: 68.44M USDP/E: —

BioPorto A/S, an in-vitro diagnostics company, focuses on developing biomarker tests to help clinicians detect the kidney injury in critically ill patients at earlier stage in Denmark, rest of Europe, North America, and …

Key Statistics

Company
Market Cap68.44M USD
Enterprise Value58.35M USD
Revenue (TTM)5.64M USD
Gross Profit4.47M USD
Net Income (TTM)-12.08M USD
Revenue/Share0.01 USD
Last Price0.1382 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees44
CountryDK
SectorHealthcare
IndustryDiagnostics & Research
ISINDK0011048619
Valuation
P/E (Trailing)—
P/E (Forward)-9.40
PEG—
EV/EBITDA-30.46
EV/Revenue10.34
P/S12.13
P/B5.66
EPS (TTM)-0.0015 USD
EPS (Forward)-0.01 USD
52W Range
0.123419% of range0.2030
52W High0.2030 USD
52W Low0.1234 USD
Profitability
Gross Margin75.44%
Oper. Margin-35.59%
EBITDA Margin-33.95%
Profit Margin-203.83%
ROE-130.33%
ROA-88.13%
ROIC-515.93%
ROCE-128.39%
Growth
Revenue Growth-34.80%
Earnings Growth—
Cash Flow & Leverage
Operating CF-11.33M USD
CapEx (TTM)—
FCF Margin-8.90%
FCF Yield-0.73%
Net Debt-10.09M USD
Net Debt/EBITDA5.27
Net Debt/FCF—
Balance Sheet
Debt/Equity0.12
Current Ratio4.09
Quick Ratio3.72
Book Value/Sh0.02 USD
Cash/Share0.02 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating0.0 (Hold)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)0.2574 USD
Upside (mean)+86.2%
Target Range0.2574 USD – 0.2574 USD
# Analysts1
Ownership
Shares Out.495.10M
Float458.86M
Insiders29.80%
Institutions6.38%
Technical
SMA 500.1548 (-10.7%)
SMA 2000.1585 (-12.8%)
Beta1.30
S&P 52W Chg8.68%
Avg Vol (30d)328.13K
Avg Vol (10d)370.81K
Technical Indicators
RSI (14)30.1
MACD-0.0251
MACD Signal-0.0223
MACD Hist.-0.0027
BB Upper0.1543 USD
BB Middle0.1467 USD
BB Lower0.1391 USD
BB Width10.35%
ATR (14)0.0045 USD
Vol Ratio (20d)0.63x

About BioPorto (CPH: BIOPOR)

›

BioPorto (CPH: BIOPOR) is listed on Nasdaq Copenhagen, where its shares trade in DKK. It belongs to the Diagnostics & Research industry, part of the Healthcare sector, and reports about 44 employees.

The shares were at 0.9400 DKK on 20 November 2026, down 16.7% over 52 weeks. Its 52-week range is 0.8390 DKK to 1.380 DKK: the price is 31.9% below the high and 12.0% above the low.

Its market capitalisation is 465.39M DKK.

BioPorto reports return on equity of -130.3%, an operating margin of -35.6% and revenue down 34.8% year over year.

It holds more cash than debt, a net cash position of 68.61M DKK. Its Piotroski F-score is 4 out of 9, an average reading of its financial health. One analyst covers the stock; their mean price target of 1.750 DKK is 86.2% above the current price.